Weill Neurohub Joins Forces With Genentech and Roche to Advance Neuroscience ResearchBusiness Wire • 02/25/21
Spark Therapeutics Further Strengthens Technical Expertise with Appointment of Cynthia Pussinen as Chief Technical OfficerGlobeNewsWire • 02/25/21
Roche announces results from Evrysdi (risdiplam) study in infants with Type 1 spinal muscular atrophy (SMA) published in New England Journal of MedicineGlobeNewsWire • 02/25/21
Genentech Announces Results From Evrysdi (risdiplam) Study in Infants With Type 1 Spinal Muscular Atrophy (SMA) Published in New England Journal of MedicineBusiness Wire • 02/24/21
Analog Devices, Inc's (ADI) CEO Vince Roche on Q1 2021 Results - Earnings Call TranscriptSeeking Alpha • 02/17/21
Roche's Faricimab On Par With Rival Regeneron's Aflibercept In Four Late-Stage Studies In Vision Loss DisorderBenzinga • 02/12/21
New phase III data show Roche's faricimab is the first investigational injectable eye medicine to extend time between treatments up to four months in two leading causes of vision loss, potentially reducing treatment burden for patientsGlobeNewsWire • 02/12/21
New Phase III Data Show Genentech's Faricimab Is the First Investigational Injectable Eye Medicine to Extend Time Between Treatments up to Four Months in Two Leading Causes of Vision Loss, Potentially Reducing Treatment Burden for PatientsBusiness Wire • 02/12/21
Roche announces the filing for FDA Emergency Use Authorization for SARS-CoV-2 Rapid Antigen Test, allowing healthcare professionals to make fast decisions at the point of carePRNewsWire • 02/08/21
FDA grants Breakthrough Device Designation for Roche's Elecsys Growth Differentiation Factor-15 (GDF-15) assay to help identify patients suitable for innovative treatment addressing unintentional weight loss in cancer patientsGlobeNewsWire • 02/08/21
Roche Unit Spark Therapeutics' Hemophilia A Gene Therapy Shows Durable Benefit In Early-Stage StudyBenzinga • 02/05/21
Spark Therapeutics Announces Preliminary Data from Phase 1/2 Clinical Trial of SPK-8016 in Hemophilia A at EAHAD 2021 Virtual CongressGlobeNewsWire • 02/05/21
Roche Holding AG (RHHBY) CEO Severin Schwan on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/05/21
The Hanover Insurance Group's (THG) CEO Jack Roche on Q4 2020 Results - Earnings Call TranscriptSeeking Alpha • 02/04/21
Affimed Partners With Roche To Develop AFM24 Combo Therapy In EGFR Expressing Solid TumorsBenzinga • 02/03/21
Roche announces the upcoming launch of the SARS-CoV-2 Rapid Antigen Test Nasal allowing for patient self-collectionGlobeNewsWire • 02/01/21
Roche renews partnership with Sysmex to deliver haematology testing solutionsGlobeNewsWire • 01/25/21